Fungal colonization - an additional risk factor for diseased dogs and cats?

• Autorzy: Bieganska M. , Dardzinska W. , Dworecka-Kaszak B.
• Języki publikacji: EN

Abstrakty

EN

The aim of the presented mini-review is to review the literature data referring to opportunistic mycoses in pet dogs and cats suffering from other concurrent diseases, comparable to human medical disorders with high risk of secondary mycoses. This review also presents the preliminary results of a project aimed at understanding the fungal colonization and occurrence of secondary mycoses in pets suffering from metabolic disorders, neoplasms and viral infections. The incidence of opportunistic mycoses is higher in such individuals, mostly because of their impaired immunity. The main risk factors are primary and secondary types of immunodeficiency connected with anti-cancer treatment or neoplastic disease itself. Moreover, literature data and the results of our investigations show that Candida yeasts are prevalent among diabetic animals and indicate that these fungi are the main etiological agents of secondary infections of the oral cavity, GI and urogenital tracts. Other important conditions possibly favoring the development of mycoses are concurrent infections of cats with FeLV and FIV viruses. Thus, in all cases of the mentioned underlying diseases, animals should be carefully monitored by repeated mycological examination, together with inspection of other parameters. Also, the prophylaxis of opportunistic mycoses should be carefully considered alike other factors influencing the prognosis and the outcome of primary diseases.

Słowa kluczowe

EN

risk factor; animal disease; dog; cat; fungal colonization; mycosis; viral infection; diabetes; cancer

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2014
• Tom: 60
• Numer: 3
• Opis fizyczny: p.139-146,fig.,ref.

Twórcy

autor

Bieganska M.

• Division of Mycology, Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland

autor

Dardzinska W.

• Division of Mycology, Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland

autor

Dworecka-Kaszak B.

• Division of Mycology, Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland

Bibliografia

• [1] Zawirska A., Adamski Z. 2004. Systemic fungal infections – a tip of the iceberg? Nowiny Lekarskie 73: 479-482.
• [2] Batura-Gabryel H. 1999. Some aspects of candidiasis pathogenesis. Mikologia Lekarska 6: 113-118.
• [3] Batura-Gabryel H. 2003. Grzybice głębokie u chorych na AIDS. Mikologia Lekarska 10: 319-324.
• [4] Pasqualotto A.C., Rosa D.D., Medeiros L.R., Severo L.C. 2006. Candidaemia and cancer: patients are not all the same. BMC Infectious Diseases 6: 50.
• [5] Kim J., Sudbery P. 2011. Candida albicans, a major human pathogen. Journal of Microbiology 49: 171-177.
• [6] Butrym A., Zywar K., Dzietczenia J., Mazur G. 2011. Invasive fungal infections in patients with hematological malignances. Mikologia Lekarska 18: 47-53.
• [7] Sobol G., Mizia-Maziarz A., Musioł K., Krupa M., Stolpa W., Szyszka A., Walczak E., Kuleta-Bosak E., Woś H. 2009. Invasive fungal infections in children with neoplasms – single institution experience. Mikologia Lekarska 16: 67-71.
• [8] Perryman L.E. 2004. Molecular pathology of severe combined immunodeficiency in mice, horses, and dogs. Veterinary Pathology 41: 95-100.
• [9] Hildebrand W., Kuziemska A. 2011. Review and management of adverse effects of chemotherapy. Magazyn Weterynaryjny 20: 926-930.
• [10] Brown G.D. 2011. Innate antifungal immunity: the key role of phagocytes. Annual Review of Immunology 29: 1-21.
• [11] Mróz K., Saduś-Wojciechowska M., Czerw T. 2011. The dog with acute leukemia – a difficult problem in veterinary clinic. Part 2. Magazyn Weterynaryjny 20: 931-937.
• [12] Matsuda K., Sakaguchi K., Kobayashi S., Tominaga M., Hirayama K., Kadosawa T., Taniyama H. 2009. Systemic candidiasis and mesenteric mast cell tumor with multiple metastases in a dog. Journal of Veterinary Medical Sciences 71: 229-232.
• [13] Jeroski A. 2003. Multicentric lymphoma and disseminated coccidioidomycosis in a dog. Canadian Veterinary Journal 44: 62-64.
• [14] Greci V., Stefanello D., Di Giancamillo M., Mortellaro C.M. 2009. Sinonasal tumor in 3 dogs after successful topical treatment for frontal sinus aspergillosis. Canadian Veterinary Journal 50: 1191-1194.
• [15] Brunker J.D., Hoover J.P. 2007. B-cell lymphoma in a dog with ehrlichiosis (Ehrlichia canis) and systemic histoplasmosis (Histoplasma capsulatum). Canadian Veterinary Journal 48: 292-295.
• [16] Ship J.A. 2003. Diabetes and oral health: an overview. Journal of American Dental Association 134 (supl.): 4-10.
• [17] Mealey B.L, Oates T.W. 2006. Diabetes mellitus and periodontal disease. Journal of Periodontology 77: 1289-1303.
• [18] Bajaj S., Prasad S., Gupta A., Singh V.B. 2012. Oral manifestations in type-2 diabetes and related complications. Indian Journal of Endocrinology and Metabolism 16: 777-779.
• [19] Lalla R.V., D’Ambrosio J.A. 2001. Dental management considerations for the patient with diabetes mellitus. Journal of American Dental Association 132: 1425-1432.
• [20] Belazi M., Velegraki A., Fleva A., Gidarakou I., Papanaum L., Baka D., Daniilidou N., Karamitsos D. 2005. Candidal overgrowth in diabetic patients: potential predisposing factors. Mycoses 48: 192-196.
• [21] Drozdowska A., Drzewoski J. 2008. Mycoses in diabetes – difficult diagnostic and therapeutic problem. Review of literature. Diabetologia Doświadczalna i Kliniczna 8: 1-11.
• [22] Lacour M., Zunder T., Huber R., Sander A., Daschner F., Frank U. 2002. The pathogenetic significance of intestinal Candida colonization – a systematic review from an interdisciplinary and environmental medical point of view. International Journal of Hygiene and Environmental Health 205: 257-268.
• [23] Nern K. 2002. Dermatologic conditions associated with diabetes. Current Diabetes Report 2: 53-59.
• [24] Pavlović M.D., Milenković T., Dinić M., Misović M., Daković D., Todorović S., Daković Z., Zecevi R.D., Doder R. 2007. The prevalence of cutaneous manifestations in young patients with type 1 diabetes. Diabetes Care 30: 1964-1967.
• [25] Ahmed I., Goldstein B. 2006. Diabetes mellitus. Clinics in Dermatology 24: 237-246.
• [26] Yosipovitch G., Hodak E., Vardi P., Shraga I., Karp M., Sprecher E., David M. 1998. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 21: 506-509.
• [27] Sobel J.D., Chaim W., Nagappan V., Leaman D. 2003. Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. American Journal of Obstetrics and Gynecology 189: 1297-1300.
• [28] Urünsak M., Ilkit M., Evrüke C., Urünsak I. 2004. Clinical and mycological efficacy of single-day oral treatment with itraconazole (400 mg) in acute vulvovaginal candidiosis. Mycoses 47: 422-427.
• [29] Lanternier F., Lortholary O. 2009. Zygomycosis and diabetes mellitus. Clinical Microbiology and Infection 15 (Supl. 5): 21-25.
• [30] Anuradha K., Lakshmi V., Umabala P., Rao M.N. 2006. Pulmonary zygomycosis in a diabetic patient. Indian Journal of Medical Microbiology 24: 222-224.
• [31] Santelli A.N., Blair J.E., Roust L.R. 2006. Coccidioidomycosis in patients with diabetes mellitus. The American Journal of Medicine 119: 964-969.
• [32] Komase Y., Kunishima H., Yamaguchi H., Ikehara M., Yamamoto T., Shinagawa T. 2007. Rapidly progressive invasive pulmonary aspergillosis in a diabetic man. Journal of Infection and Chemotherapy 13: 46-50.
• [33] Jin Y., Lin D. 2005. Fungal urinary tract infections in the dog and cat: a retrospective study (2001-2004). Journal of American Animal Hospital Association 41: 373-381.
• [34] Cerundolo R. 2004. Generalized Microsporum canis dermatophytosis in six Yorkshire terrier dogs. Veterinary Dermatology 15: 181-187.
• [35] Heseltine J.C., Panciera D.L., Saunders G.K. 2003. Systemic candidiasis in a dog. Journal of the American Veterinary Medical Association 223: 821-824, 810.
• [36] Pressler B.M., Vaden S.L., Lane I.F., Cowgill L.D., Dye J.A. 2003. Candida spp. urinary tract infections in 13 dogs and seven cats: predisposing factors, treatment, and outcome. Journal of American Animal Hospital Association 39: 263-270.
• [37] Biegańska M., Dardzińska W., Czopowicz M., Dworecka-Kaszak B. 2012. Frequency of yeasts isolated from dogs and cats with various factors predisposing to opportunistic infections. Proceedings of XIII Conference Diagmol 2012, WULS0-SGGW, Warsaw, Poland: 102-106.
• [38] US Food and Drug Administration. 2014. Treating Cushing’s Disease in Dogs. http://www.fda.gov/forconsumers/consumerupdates/ucm151209.htm
• [39] Stuck A.E, Minder C.E, Frey F.J. 1989. Risk of infectious complications in patients taking glucocorticosteroids. Review of Infectious Diseases 11: 954-963.
• [40] Sarlis N.J, Chanock S.J, Nieman L.K. 2000. Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. Journal of Clinical Endocrinology and Metabolism 85: 42-47.
• [41] Nichols R. 1997. Complications and concurrent disease associated with canine hyperadrenocorticism. The Veterinary Clinics of North America: Small Animal Practice 27: 309-320.
• [42] Frank L.A. 2006. Comparative dermatology-canine endocrine dermatoses. Clinics in Dermatology 24: 317-325.
• [43] Zur G., White S.D. 2011. Hyperadrenocorticism in 10 dogs with skin lesions as the only presenting clinical signs. Journal of American Animal Hospital Association 47: 419-427.
• [44] Julián-González R.E., Valdebrán-Canales M.A., Guidos-Morales H.E. 2010. Chronic mucocutaneous candidiasis: Case report. Archivos Argentinos de Pediatria 108: 37-40.
• [45] Addie D.D., Dennis J.M., Toth S., Callanan J.J., Reid S., Jarrett O. 2000. Long-term impact on a closed household of pet cats of natural infection with feline coronavirus, feline leukaemia virus and feline immunodeficiency virus. Veterinary Record 146: 419-424.
• [46] Quackenbush S.L., Donahue P.R., Dean G.A., Myles M.H., Ackley C.D., Cooper M.D., Mullins J.I., Hoover E.A. 1990. Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. Journal of Virology 64: 5465-5474.
• [47] Hoffmann-Fezer G., Mortelbauer W., Hartmann K., Mysliwietz J., Thefeld S., Beer B., Thum I., Kraft W. 1996. Comparison of T-cell subpopulations in cats naturally infected with feline leukaemia virus or feline immunodeficiency virus. Research in Veterinary Science 61: 222-226.
• [48] Linenberger M.L., Deng T. 1999. The effects of feline retroviruses on cytokine expression. Veterinary Immunology and Immunopathology 72: 343-368.
• [49] McCaw D.L. 2012. Overview of feline leukemia virus and related diseases. In: The MERC Veterinary Manual.http://www.merckmanuals.com/vet generalized_conditions/feline_leukemia_virus_and_related_diseases /overview_of_feline_leukemia_virus_and_related_diseases.html
• [50] Sierra P., Guillot J., Jacob H., Bussiéras S., Chermette R. 2000. Fungal flora on cutaneous and mucosal surfaces of cats infected with feline immunodeficiency virus or feline leukemia virus. American Journal of Veterinary Research 61: 158-161.
• [51] Tizard I. 2013. Feline Immunodeficiency Virus. In: Secondary Immunodeficiencies. The MERC Veterinary Manual http://www.merckmanuals.com/vet/immune_system/immunologic_diseases/secondary_immunodeficiencies.html#v3277197
• [52] Reche A.Jr., Daniel A.G., Lazaro Strauss T.C., Taborda C.P., Vieira Marques S.A., Haipek K., Oliveira L.J., Monteiro J.M., Kfoury J.R.Jr. 2010. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus. Journal of Feline Medicine and Surgery 12: 355-358.
• [53] Davies C., Troy G.C. 1996. Deep mycotic infections in cats. Journal of the American Animal Hospital Association 32: 380-391.
• [54] Jacobs G.J., Medleau L., Calvert C., Brown J. 1997. Cryptococcal infection in cats: factors influencing treatment outcome, and results of sequential serum antigen titers in 35 cats. Journal of Veterinary Internal Medicine 11: 1-4.
• [55] Schubach T.M., Schubach A., Okamoto T., Barros M.B., Figueiredo F.B., Cuzzi T., Fialho-Monteiro P.C., Reis R.S., Perez M.A., Wanke B. 2004. Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001). Journal of American Veterinary Medical Association 224: 1623-1629.
• [56] Greene R.T., Troy G.C. 1995. Coccidioidomycosis in 48 cats: a retrospective study (1984-1993). Journal of Veterinary Internal Medicine 9: 86-91.